Tvardi Therapeutics, Inc.
USD1.79
-0.12 (-6.28%)
CEO
Imran Alibhai
IPO Date
2014-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.83
Prev. Close
$1.91
Day Low
$1.71
Day High
$1.86
52W Low
$1.50
52W High
$43.65
Market Cap
$0.02B
Volume
0.16M
| 6,000 |
| $2.78 |
| 11 Jun 2026 | Shah Sujal | director | A-Award | Acquired | 6,000 | $2.78 |
| 11 Jun 2026 | HALL WALLACE L JR | director | A-Award | Acquired | 6,000 | $2.78 |
| 11 Jun 2026 | WYZGA MICHAEL S | director | A-Award | Acquired | 6,000 | $2.78 |
| 2 Feb 2026 | O'Brien Stephen Paul | Principal Accounting Officer | A-Award | Acquired | 15,000 | $3.90 |
| 2 Feb 2026 | Conn Avi Daniel | Chief Financial Officer | A-Award | Acquired | 45,000 | $3.90 |
| 2 Feb 2026 | Kauh John Saewook M.D. | Chief Medical Officer | A-Award | Acquired | 45,000 | $3.90 |
| 2 Feb 2026 | Alibhai Imran Nizamudin | director, officer: Chief Executive Officer | A-Award | Acquired | 115,000 | $3.90 |
| 18 Dec 2025 | O'Brien Stephen Paul | Principal Accounting Officer | A-Award | Acquired | 4,000 | $4.20 |